We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Your Password has changed! Please login again
Cart
Outdated Browser Detected
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features.
Please use one of the below recommended browsers to improve your browsing experience
Today’s business environment demands a seamless and continual transition of digital experience to conduct business and engage various stakeholders in the same way we conduct the rest of our lives outside work. The experience expectation is consistent across devices of choice from phones to tablets to laptops. That’s why West partners with the world’s top pharmaceutical, biotech, device and diagnostic companies to embrace technology that supports the patients they serve with online resources and tools to better manage their health. In turn, we’re looking to support our customers with digital tools to help speed the research and development process of bringing life-saving medicines to patients that need them.
Companies seeking to bring an injectable medicine to market are required to complete an immense amount of research on the medicine itself, but they must also study the containment or device options to help ensure that medicine is delivered safely to the patient. The regulatory hurdles associated with combination therapies that include both the medicine, together with a device, represent a host of additional regulatory requirements.
To support customers, West’s Knowledge Center offers an online repository of scientific and regulatory support content that can help customers get the information they need quickly to manage this regulatory process. West also offers commonly requested, detailed product information, including specifications and drawings, on our entire portfolio of elastomer packaging components, pre-filled syringe solutions and wearable devices. Recently, we added the ability to purchase some of these same products through our online store. All of these services are available across a range of digital platforms, so that customers can easily access this information 24 hours a day, regardless of the device they use.
This is just one of the ways West is working to Simplify the Journey™ for our customers, by making it easier for our customers to do what we consider to be some of life’s most important work—developing innovative new medicines to address unmet medical needs. To learn more watch the above video or visit the West Knowledge center.
#SimplifytheJourney #WestByYourSide
Simplify the Journey™ is a trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
With the advancement of high-value biologic,<span> gene, and cell therapy drugs, there is a growing interest in assessment of container closure systems (CCS) at the low temperatures experienced during processing, storage, and shipment. A vial-based CCS is usually capped at room temperature, but thereafter it may be exposed to low temperature conditions (0<sup>o</sup>C to -180<sup>o</sup>C), depending on both the drug characteristics and the expected duration of storage. </span>
Qingyu Zeng Ph.D.
Fellow Scientist and Technical Director, Scientific Insights Lab
West is pleased to kick off the West without Borders fundraising initiative for 2013! In 2012, our global team raised more than $260,000 for local charities that aid children in need. This year, we have once again chosen to aid children by supporting charities located close to our facilities.
Modern biopharmaceutical drug molecules are often complex protein structures that need to maintain the molecular structure in order to convey full potency. With biologics, any alteration of the 3-D structure could lead to loss of activity or even to immunogenic reactions in the patient. Proteins can be disrupted by interactions with the container closure or with leachables. West FluroTec® lamination was chosen for NovaPure® plungers to reduce the interaction between the drug product and elastomer material. This includes less adsorption to the plunger surface as well as reduction of the leachables profile of the plunger, helping to maintain the stability of complex molecules.
Liquid injectable drugs can be contained in a pre-filled syringe system, a cartridge-based system, or a vial-based system (with a rubber stopper and seal). For a vial-based system, the drugs first are aseptically filled into glass or polymer vials. During the subsequent Fill & Finish operations, the vials are closed temporarily by inserting a rubber stopper into the vial orifice. This is prior to crimping with an aluminum seal, which results in the final integral vial-based container closure system.
Innovation in manufacturing involves a spectrum of evolutionary improvements resulting in what West’s partner Daikyo Seiko, Ltd. considers as “Absolute Quality.” Recent continuous improvement efforts helped Daikyo achieve even higher levels in cleanliness of elastomer products.<br />